Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)
Clinical trial NCT01536405 · COMPLETED
Trial details
- NCT number
- NCT01536405
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-05
- Primary completion
- 2013-07-02
- Enrollment
- 1412
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.